Temporal Trends and Regional Disparities in Knee Osteoarthritis Across the United Kingdom: Insights From the Global Burden of Disease Study 1990-2021

英国膝骨关节炎的时间趋势和区域差异:来自1990-2021年全球疾病负担研究的启示

阅读:1

Abstract

Background and aim Knee osteoarthritis (OA) is a major cause of pain, disability, and reduced quality of life, with its burden rising due to ageing, obesity, and lifestyle changes. This study analysed the trends between 1990 and 2021 in the prevalence, incidence, years lived with disability (YLDs), and disability-adjusted life years (DALYs) for knee OA across the four UK nations (England, Northern Ireland, Scotland, and Wales) using Global Burden of Disease data. Methods We extracted age-standardised and absolute estimates of prevalence, incidence, YLDs, and DALYs for knee OA in the UK and its four nations from the GBD 2021 database. Joinpoint regression analysis was applied to quantify annual percent change (APC) and average annual percent change (AAPC) in disease burden over time. Temporal patterns and inter-regional differences were assessed. Results From 1990 to 2021, the knee OA burden increased across all UK nations. England had the highest absolute prevalence, with knee OA rising from 3.02 million to 4.51 million cases (+49.2%), while Northern Ireland showed the largest relative increase (+76.4%). Women consistently had 30%-40% higher rates than men, with 2021 prevalence reaching 5,226.8 per 100,000 in England versus 3,753.2 in men. YLD rates rose by 7.16% in England and 7.94% in Scotland. DALYs increased most in Scottish men (+11.0%), and Northern Ireland recorded the fastest prevalence growth. England's burden peaked around 2015 before stabilising. Conclusion The burden of knee OA in the UK has risen markedly over the past three decades, with persistent regional disparities. These findings highlight the need for targeted prevention strategies, early diagnosis, and equitable access to joint-preserving interventions. Public health policies addressing obesity, promoting physical activity, and improving OA management could help mitigate future disease burden.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。